These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 1403784

  • 21. Characterization of the estrogen receptor in two antiestrogen-resistant cell lines, LY2 and T47D.
    Mullick A, Chambon P.
    Cancer Res; 1990 Jan 15; 50(2):333-8. PubMed ID: 2295073
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer.
    Kim R, Tanabe K, Emi M, Uchida Y, Osaki A, Toge T.
    Int J Oncol; 2005 Apr 15; 26(4):1025-31. PubMed ID: 15753998
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Antiestrogenic and DNA damaging effects induced by tamoxifen and toremifene metabolites.
    Liu X, Pisha E, Tonetti DA, Yao D, Li Y, Yao J, Burdette JE, Bolton JL.
    Chem Res Toxicol; 2003 Jul 15; 16(7):832-7. PubMed ID: 12870885
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. 9-Cis retinoic acid inhibits growth of breast cancer cells and down-regulates estrogen receptor RNA and protein.
    Rubin M, Fenig E, Rosenauer A, Menendez-Botet C, Achkar C, Bentel JM, Yahalom J, Mendelsohn J, Miller WH.
    Cancer Res; 1994 Dec 15; 54(24):6549-56. PubMed ID: 7987855
    [Abstract] [Full Text] [Related]

  • 30. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen.
    Morrissey JJ, Raney S.
    Cell Biol Int; 1998 Dec 15; 22(6):413-9. PubMed ID: 10328849
    [Abstract] [Full Text] [Related]

  • 31. Genetic instability and the development of steroid hormone insensitivity in cultured T 47D human breast cancer cells.
    Reddel RR, Alexander IE, Koga M, Shine J, Sutherland RL.
    Cancer Res; 1988 Aug 01; 48(15):4340-7. PubMed ID: 3390830
    [Abstract] [Full Text] [Related]

  • 32. Retinoic acid induces expression of the interleukin-1beta gene in cultured normal human mammary epithelial cells and in human breast carcinoma lines.
    Liu L, Gudas LJ.
    J Cell Physiol; 2002 Nov 01; 193(2):244-52. PubMed ID: 12385002
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The alkaloid Berberine inhibits the growth of Anoikis-resistant MCF-7 and MDA-MB-231 breast cancer cell lines by inducing cell cycle arrest.
    Kim JB, Yu JH, Ko E, Lee KW, Song AK, Park SY, Shin I, Han W, Noh DY.
    Phytomedicine; 2010 May 01; 17(6):436-40. PubMed ID: 19800775
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Antiestrogen, trans-tamoxifen modulation of human breast cancer cell growth.
    Lee HO, Sheen YY.
    Arch Pharm Res; 1997 Dec 01; 20(6):572-8. PubMed ID: 18982262
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Combined effects of RU486 and tamoxifen on the growth and cell cycle phases of the MCF-7 cell line.
    Thomas M, Monet JD.
    J Clin Endocrinol Metab; 1992 Sep 01; 75(3):865-70. PubMed ID: 1517379
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.